Status:
RECRUITING
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Myocardial Injury
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The present retrospective and prospective observational study aims at evaluate the clinical predictors of myocardial injury in patients hospitalized for COVID-19 infection since the introduction of va...
Detailed Description
Background: Coronavirus disease-2019 (COVID-19) is a global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is resulting in substantial morbidity and mo...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Overt COVID-19 infection (molecular nasopharyngeal swab positive for SARS-CoV-2 ≥1);
- Patient with at least a high sensitivity Troponin I measured during hospitalization course.
- Available data on vaccination.
- Verbal informed consent
Exclusion
- Age \<18 years;
- Patient in whom at least one high sensitivity Troponin I value measured during the course of hospitalization is not available.
- No data available on vaccination status.
Key Trial Info
Start Date :
May 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT05392088
Start Date
May 6 2022
End Date
August 1 2024
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy, 00168